Domicile
Reels
Groupes
Pages
Plus
Groupes Pages Evènements Blogs Offres Emplois Courses Forums Film Merits
Se connecter S’enregistrer
Sélecteur de thème
Mode nuit
Acute Myeloid Testing Market at a CAGR of 13.70% in the forecast period of 2022-2029.
Introduction The acute myeloid leukemia (AML) testing market has become a critical segment within the broader field of oncology diagnostics. AML is an aggressive cancer of the blood and bone marrow characterized by the rapid growth of abnormal myeloid cells. It accounts for a significant proportion of leukemia cases worldwide and is associated with high morbidity and mortality rates....
0 Commentaires ·0 Parts ·42 Vue ·0 Aperçu
Connectez-vous pour aimer, partager et commenter!